-
1081por Lener, Marcin R., Scott, Rodney J., Wiechowska-Kozłowska, Anna, Serrano-Fernández, Pablo, Baszuk, Piotr, Jaworska-Bieniek, Katarzyna, Sukiennicki, Grzegorz, Marciniak, Wojciech, Muszyńska, Magdalena, Kładny, Józef, Gromowski, Tomasz, Kaczmarek, Katarzyna, Jakubowska, Anna, Lubiński, Jan“…PURPOSE: Understanding of the etiology and pathogenesis of pancreatic cancer (PaCa) is still insufficient. This study evaluated the associations between concentrations of selenium (Se) and copper (Cu) in the serum of PaCa patients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1082por Xu, Yong, Liu, Ping, Zheng, Dong-Hui, Wu, Nan, Zhu, Lun, Xing, Changying, Zhu, Jin“…The elevation of Nicotinamide N-methyltransferase (NNMT) has been reported in pancreatic cancer tissues and cell lines, but its clinical and prognostic implications remain controversial. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1083“…Survival from pancreatic cancer remains poor. Conventional treatment has resulted in only marginal improvements in survival compared with survival in the previous several decades. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1084
-
1085por Aroldi, Francesca, Bertocchi, Paola, Savelli, Giordano, Rosso, Edoardo, Zaniboni, Alberto“…Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1086por Takasawa, Akira, Murata, Masaki, Takasawa, Kumi, Ono, Yusuke, Osanai, Makoto, Tanaka, Satoshi, Nojima, Masanori, Kono, Tsuyoshi, Hirata, Koichi, Kojima, Takashi, Sawada, Norimasa“…Nuclear localization of tricellulin promoted cell proliferation and invasiveness possibly in association with MAPK and PKC pathways in pancreatic cancers. Our results provide new insights into the function of tricellulin, and its nuclear localization may become a new prognostic factor for pancreatic cancers.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1087por Yoshida, Eri, Kudo, Daisuke, Nagase, Hayato, Shimoda, Hiroshi, Suto, Shinichiro, Negishi, Mika, Kakizaki, Ikuko, Endo, Masahiko, Hakamada, Kenichi“…However, the localization of HA and the changes in ECM morphology caused by MU in pancreatic cancer remain to be examined in detail. In the present study, the cytotoxicity of MU and its effect on cellular proliferation was evaluated in the human pancreatic cancer cell line MIA PaCa-2. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1088por Hauptmann, Michael, Børge Johannesen, Tom, Gilbert, Ethel S, Stovall, Marilyn, van Leeuwen, Flora E, Rajaraman, Preetha, Smith, Susan A, Weathers, Rita E, Aleman, Berthe M P, Andersson, Michael, Curtis, Rochelle E, Dores, Graça M, Fraumeni Jr, Joseph F, Hall, Per, Holowaty, Eric J, Joensuu, Heikki, Kaijser, Magnus, Kleinerman, Ruth A, Langmark, Frøydis, Lynch, Charles F, Pukkala, Eero, Storm, Hans H, Vaalavirta, Leila, van den Belt-Dusebout, Alexandra W, Morton, Lindsay M, Fossa, Sophie D, Travis, Lois B“…BACKGROUND: Pancreatic cancer risk is elevated among testicular cancer (TC) survivors. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1089“…Surgical resection is the only possible curative mode of treatment. Metastatic pancreatic cancer is incurable with modest results from the current treatment options. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1090por Jiang, Zhenyang, Butler-Bowen, Harriet, Rodriguez, Teresa, Garcon, Marie C., Smith, Melissa Hennessey, Relias, Valerie, Saif, Muhammad Wasif“…BACKGROUND: Fatigue is a common but devastating symptom for advanced pancreatic cancer (APC) patients. To date, no proven treatment exists. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1091por Li, Liang, Zhang, Jian-Wei, Jenkins, Gregory, Xie, Fang, Carlson, Erin E., Fridley, Brooke L., Bamlet, William R., Petersen, Gloria M., McWilliams, Robert R., Wang, Liewei“…BACKGROUND: Pancreatic cancer is a rapidly fatal disease with gemcitabine remaining the first-line therapy. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1092por Omura, Noriyuki, Mizuma, Masamichi, MacGregor, Anne, Hong, Seung-Mo, Ayars, Michael, Almario, Jose Alejandro, Borges, Michael, Kanda, Mitsuro, Li, Ang, Vincent, Audrey, Maitra, Anirban, Goggins, Michael“…Using methylated CpG island amplification and promoter microarrays, we identified ANK1 as hypomethylated in pancreatic cancers. Expression analysis determined ANK1 as commonly overexpressed in pancreatic cancers relative to normal pancreas. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1093por Li, J, Gu, D, Lee, S S-Y, Song, B, Bandyopadhyay, S, Chen, S, Konieczny, S F, Ratliff, T L, Liu, X, Xie, J, Cheng, J-X“…Collectively, our results demonstrate a new strategy for treating metastatic pancreatic cancer by inhibiting cholesterol esterification.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1094por Tsuchikawa, Takahiro, Takeuchi, Shintaro, Nakamura, Toru, Shichinohe, Toshiaki, Hirano, Satoshi“…Here we review the recent advances of chemotherapy to improve tumor microenvironment of pancreatic cancer, introducing the unique feature of tumor microenvironment of pancreatic cancer, interaction between anti-cancer reagents and these constituting cells and future prospects.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1095por Matsukuma, Satoshi, Yoshimura, Kiyoshi, Ueno, Tomio, Oga, Atsunori, Inoue, Moeko, Watanabe, Yusaku, Kuramasu, Atsuo, Fuse, Masanori, Tsunedomi, Ryouichi, Nagaoka, Satoshi, Eguchi, Hidetoshi, Matsui, Hiroto, Shindo, Yoshitaro, Maeda, Noriko, Tokuhisa, Yoshihiro, Kawano, Reo, Furuya‐Kondo, Tomoko, Itoh, Hiroshi, Yoshino, Shigefumi, Hazama, Shoichi, Oka, Masaaki, Nagano, Hiroaki“…Multivariate analysis identified CRT as an independent prognostic factor for pancreatic cancer patients, along with age and postoperative therapy. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1096por Susanto, Hendra, Liu, Ta-Yu, Chen, Chang-Chiang, Purnomo, Jerry D.T., Chen, Shu-Fan, Wang, Chih-Hong“…Long-standing diabetes or glucose intolerance is recognized as a crucial event in the process of pancreatic cancer. Betatrophin, a novel liver-derived hormone, promotes β-cell proliferation and improves glucose intolerance. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1097por Martínez-Bosch, Neus, Guerrero, Pedro Enrique, Moreno, Mireia, José, Anabel, Iglesias, Mar, Munné-Collado, Jessica, Anta, Héctor, Gibert, Joan, Orozco, Carlos Alberto, Vinaixa, Judith, Fillat, Cristina, Viñals, Francesc, Navarro, Pilar“…We tested the therapeutic effects of sunitinib in pancreatic cancer using the Ela-myc transgenic mouse model. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1098por Lubeseder-Martellato, Clara, Hidalgo-Sastre, Ana, Hartmann, Carolin, Alexandrow, Katharina, Kamyabi-Moghaddam, Zahra, Sipos, Bence, Wirth, Matthias, Neff, Florian, Reichert, Maximilian, Heid, Irina, Schneider, Günter, Braren, Rickmer, Schmid, Roland M., Siveke, Jens T.“…In addition, we show that CD24 protein is stabilized in response to WNT activation and that overexpression of CD24 in pancreatic cancer cells upregulated β-catenin expression augmenting an epithelial, non-metastatic signature. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1099“…Although intensified cytostatic combinations, particularly gemcitabine plus nab-paclitaxel and the folinic acid, fluorouracil, irinotecan, oxaliplatin (FOLFIRINOX) protocol, provide some improvement in efficacy and survival compared with gemcitabine alone, a breakthrough in the treatment of metastatic pancreatic cancer remains out of sight. Nevertheless, recent translational research activities propose that either modulation of the immune response or pharmacological targeting of epigenetic modifications alone, or in combination with chemotherapy, might open highly powerful therapeutic avenues in GI cancer entities, including pancreatic cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1100“…A number of studies have examined the associations between dietary patterns and pancreatic cancer risk, but the findings have been inconclusive. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto